Stragliotto, G <br/><br/>
Multiple infusions of anti-epidermal growth factor receptor (EGFR) monoclonal antibody (EMD 55,900) in patients with recurrent malignant gliomas.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Apr 1996 
 - 636-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/0959-8049(95)00592-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Anti-Idiotypic--blood<br/>Antibodies, Monoclonal--adverse effects<br/>Brain Neoplasms--therapy<br/>Disease Progression<br/>ErbB Receptors--immunology<br/>Female<br/>Glioblastoma--therapy<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--blood<br/>Prospective Studies<br/>Survival Analysis